BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21979893)

  • 21. Genome-wide molecular characterization of central nervous system primitive neuroectodermal tumor and pineoblastoma.
    Miller S; Rogers HA; Lyon P; Rand V; Adamowicz-Brice M; Clifford SC; Hayden JT; Dyer S; Pfister S; Korshunov A; Brundler MA; Lowe J; Coyle B; Grundy RG
    Neuro Oncol; 2011 Aug; 13(8):866-79. PubMed ID: 21798848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extensive genomic abnormalities in childhood medulloblastoma by comparative genomic hybridization.
    Reardon DA; Michalkiewicz E; Boyett JM; Sublett JE; Entrekin RE; Ragsdale ST; Valentine MB; Behm FG; Li H; Heideman RL; Kun LE; Shapiro DN; Look AT
    Cancer Res; 1997 Sep; 57(18):4042-7. PubMed ID: 9307291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of genetic and chromosomal aberrations in medulloblastomas and primitive neuroectodermal tumors with DNA microarrays.
    Kagawa N; Maruno M; Suzuki T; Hashiba T; Hashimoto N; Izumoto S; Yoshimine T
    Brain Tumor Pathol; 2006 Apr; 23(1):41-7. PubMed ID: 18095118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromosome 9q and 16q loss identified by genome-wide pooled-analysis are associated with tumor aggressiveness in patients with classic medulloblastoma.
    Coco S; Valdora F; Bonassi S; Scaruffi P; Stigliani S; Oberthuer A; Berthold F; Andolfo I; Servidei T; Riccardi R; Basso E; Iolascon A; Tonini GP
    OMICS; 2011 May; 15(5):273-80. PubMed ID: 21348762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isochromosome 17q is a negative prognostic factor in poor-risk childhood medulloblastoma patients.
    Pan E; Pellarin M; Holmes E; Smirnov I; Misra A; Eberhart CG; Burger PC; Biegel JA; Feuerstein BG
    Clin Cancer Res; 2005 Jul; 11(13):4733-40. PubMed ID: 16000568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic profiling by array comparative genomic hybridization reveals novel DNA copy number changes in breast phyllodes tumours.
    Kuijper A; Snijders AM; Berns EM; Kuenen-Boumeester V; van der Wall E; Albertson DG; van Diest PJ
    Cell Oncol; 2009; 31(1):31-9. PubMed ID: 19096148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-resolution array-based comparative genomic hybridization of medulloblastomas and supratentorial primitive neuroectodermal tumors.
    McCabe MG; Ichimura K; Liu L; Plant K; Bäcklund LM; Pearson DM; Collins VP
    J Neuropathol Exp Neurol; 2006 Jun; 65(6):549-61. PubMed ID: 16783165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytogenetic and molecular biological characterization of an adult medulloblastoma.
    Holland H; Koschny R; Krupp W; Meixensberger J; Bauer M; Schober R; Kirsten H; Ganten TM; Ahnert P
    Cancer Genet Cytogenet; 2007 Oct; 178(2):104-13. PubMed ID: 17954265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Supratentorial primitive neuroectodermal tumors of the central nervous system frequently harbor deletions of the CDKN2A locus and other genomic aberrations distinct from medulloblastomas.
    Pfister S; Remke M; Toedt G; Werft W; Benner A; Mendrzyk F; Wittmann A; Devens F; von Hoff K; Rutkowski S; Kulozik A; Radlwimmer B; Scheurlen W; Lichter P; Korshunov A
    Genes Chromosomes Cancer; 2007 Sep; 46(9):839-51. PubMed ID: 17592618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma.
    Pfaff E; Remke M; Sturm D; Benner A; Witt H; Milde T; von Bueren AO; Wittmann A; Schöttler A; Jorch N; Graf N; Kulozik AE; Witt O; Scheurlen W; von Deimling A; Rutkowski S; Taylor MD; Tabori U; Lichter P; Korshunov A; Pfister SM
    J Clin Oncol; 2010 Dec; 28(35):5188-96. PubMed ID: 21060032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Array CGH analysis of pediatric medulloblastomas.
    Rossi MR; Conroy J; McQuaid D; Nowak NJ; Rutka JT; Cowell JK
    Genes Chromosomes Cancer; 2006 Mar; 45(3):290-303. PubMed ID: 16320246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microarray-based screening for molecular markers in medulloblastoma revealed STK15 as independent predictor for survival.
    Neben K; Korshunov A; Benner A; Wrobel G; Hahn M; Kokocinski F; Golanov A; Joos S; Lichter P
    Cancer Res; 2004 May; 64(9):3103-11. PubMed ID: 15126347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accumulation of genomic aberrations during clinical progression of medulloblastoma.
    Korshunov A; Benner A; Remke M; Lichter P; von Deimling A; Pfister S
    Acta Neuropathol; 2008 Oct; 116(4):383-90. PubMed ID: 18704466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene aberrations in childhood brain tumors.
    Kucerová H; Stejskalová E; Vícha A; Tichý M; Chánová M; Sumerauer D; Koutechký J; Eckschlager T
    Folia Biol (Praha); 2000; 46(5):187-90. PubMed ID: 11055797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel mechanisms of gene disruption at the medulloblastoma isodicentric 17p11 breakpoint.
    McCabe MG; Ichimura K; Pearson DM; Liu L; Clifford SC; Ellison DW; Collins VP
    Genes Chromosomes Cancer; 2009 Feb; 48(2):121-31. PubMed ID: 18973140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isochromosome breakpoints on 17p in medulloblastoma are flanked by different classes of DNA sequence repeats.
    Mendrzyk F; Korshunov A; Toedt G; Schwarz F; Korn B; Joos S; Hochhaus A; Schoch C; Lichter P; Radlwimmer B
    Genes Chromosomes Cancer; 2006 Apr; 45(4):401-10. PubMed ID: 16419060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative genomic hybridization of medulloblastomas and clinical relevance: eleven new cases and a review of the literature.
    Gilhuis HJ; Anderl KL; Boerman RH; Jeuken JM; James CD; Raffel C; Scheithauer BW; Jenkins RB
    Clin Neurol Neurosurg; 2000 Dec; 102(4):203-209. PubMed ID: 11154805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Detection of chromosomal DNA imbalance in medulloblastoma by comparative genomic hybridization].
    Sun YJ; Yu SZ; Sun CY; Wang Q; Jin SM; Wu WX; An TL
    Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):606-10. PubMed ID: 21092588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays.
    Chen M; Ye Y; Yang H; Tamboli P; Matin S; Tannir NM; Wood CG; Gu J; Wu X
    Int J Cancer; 2009 Nov; 125(10):2342-8. PubMed ID: 19521957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-level copy gain versus amplification of myc oncogenes in medulloblastoma: utility in predicting prognosis and survival. Laboratory investigation.
    Takei H; Nguyen Y; Mehta V; Chintagumpala M; Dauser RC; Adesina AM
    J Neurosurg Pediatr; 2009 Jan; 3(1):61-5. PubMed ID: 19119907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.